Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T

Clinical Chemistry

Volumn 55, Issue 6, 2009, Pages 1118-1125

  Windhausen, Fons ^a   Hirsch, Alexander ^a   Fischer, Johan ^a   Van Der Zee, P Marc ^a   Sanders, Gerard T ^a   Van Straalen, Jan P ^a   Cornel, Jan Hein ^b   Tijssen, Jan G P ^a   Verheugt, Freek W A ^c   De Winter, Robbert J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INVASIVE PROCEDURE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PATIENT CODING; PROGNOSIS; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; CYSTATIN C; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; TROPONIN T;

EID: 66549090699     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.119669     Document Type: Article

References (15)

1. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002;106:974-980
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305 (Pubitemid 39268908)
3. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-1295 (Pubitemid 39258422)
4. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004;110:2342-2348 (Pubitemid 39407337)
5. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-2060 (Pubitemid 40664306)
6. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:173-179 (Pubitemid 46105715)
7. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50:e1-e157.
8. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007;28:1598-1660 (Pubitemid 47227122)
9. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375 (Pubitemid 27506242)
10. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264 (Pubitemid 34535335)
11. Johnston N, Jernberg T, Lagerqvist B, Wallentin L. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease. Am Heart J 2006;152:1052-1058 (Pubitemid 44856711)
12. Hirsch A, Windhausen F, Tijssen JG, Verheugt FW, Cornel JH, de Winter RJ, and for the Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) investigators. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet 2007;369:827-835
13. de Winter RJ, Windhausen F, Cornel JH, Dunselman PHJM, Janus CL, Bendermacher PEF, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005;353:1095-1104 (Pubitemid 41317432)
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
15. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502-1513